Almac commits to be net zero by 2045
Find out more in our Corporate Social Responsibility Report 2022
Almac Group is proud of its global reputation for excellence, delivering expertise right across the drug development lifecycle and offering a tailored solution to each client.
Our client relationships are long term and they are underpinned by one simple commitment:
We will be exceptional, always.
Almac Diagnostic Services updates claraᵀ report with significant new content for cancer research
Almac Announces Launch of IXRS®3 Partnership Network
Almac Appoints Global Energy Manager as part of ongoing commitment to net zero strategy
Almac Group Awarded with Six CDMO Leadership Awards Across all Core Categories
25 June 2023 Boston, MA
28 June 2023 75 Northern Ave, Boston, MA 02210
4 July 2023 Basel, Switzerland